Baylon, Erwin B.

HRN: 09-69-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2026
MUPIROCIN 2%, 15G (TUBE)
01/17/2026
01/24/2026
TOPICAL
Apply On Affected Area
BID
CT Site Prophylaxis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: